• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer

    2018-03-08 06:26:34WuhaoHuangShengguangWangHuaZhangBinZhangChangliWang
    Cancer Biology & Medicine 2018年1期

    Wuhao Huang, Shengguang Wang, Hua Zhang, Bin Zhang, Changli Wang

    Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Ministry of Education, Tianjin’s Clinical Research Center for Cancer; Tianjin Lung Cancer Center, Tianjin 300060, China

    Introduction

    Lung cancer is the leading cause of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC)accounting for approximately 80% of all cases1. Despite the recent improvements in treatment and diagnosis of lung cancer, its prognosis remains unsatisfactory, with a low fiveyear survival rate of about 15% at diagnosis. Currently, the new strategy in tumor therapy focuses on using a suitable prognostic factor to make the appropriate risk classification of patients with tumors and to design subsequent treatment.Although multiple studies have found a large number of prognostic indicators for patients with NSCLC, the majority of these indicators are not available preoperatively.

    Cancer-related inflammation plays an important role in tumor progression and survival2. Cancer-related inflammation, as the 7thhallmark of cancer, promotes the proliferation and invasion of tumor cells and accelerates metastasis3. Moreover, most systemic symptoms associated with cancer, including weight loss, cachexia, and anemia, are stimulated by inflammation4. The neutrophil-to-lymphocyte ratio (NLR), as a representative index, can be considered a useful marker to assess the inflammatory response5. An increased NLR promotes tumor progression and relates to poor prognoses in a variety of cancers, such as NSCLC,esophageal cancer, and gastric cancer6-8. In terms of the systemic inflammatory response, the coagulation cascade also plays a pivotal role in tumor progression and metastasis9.Liver-produced fibrinogen is an important acute phase protein. Fibrinogen, as a key factor in the coagulation cascade, is converted into fibrin under the action of activated thrombin. Hyperfibrinogenemia is involved in cancer aggressiveness in various types of malignancies10-12. Recently,several studies analyzed a novel prognostic index, that is, the combination of fibrinogen and NLR (F-NLR). F-NLR has been found to be a significant prognostic factor in different types of cancers, such as gastric cancer, esophageal carcinoma, and NSCLC13-16.

    The present study aimed to evaluate the clinical significance of a novel prognostic system based on fibrinogen concentration and NLR in patients with NSCLC undergoing complete resection. This study also assessed the association between the three F-NLR groups and the clinicopathologic characteristics or the clinical laboratory variables.

    Materials and methods

    Patients

    We performed a retrospective study of patients with NSCLC who underwent complete surgical resection at the Tianjin Medical University Cancer Institute and Hospital between January 2006 and December 2009. The major inclusion criteria were pathological confirmation of primary NSCLC and complete surgical resection. The exclusion criteria were as follows: preoperative treatment (including chemotherapy or radiotherapy), residual tumor cells in the surgical edge,continuous anticoagulant therapy, hematological disease,autoimmune disease, and infection. Patients with intravenous or arterial embolization within 3 months before the surgery were also excluded. Based on the inclusion and exclusion criteria, 589 patients were enrolled in our study.This study was approved by the Ethical Committees of Tianjin Medical University Cancer Institute and Hospital.Prior to the treatment, and written informed consent from all participants were acquired.

    Based on the medical records, we collected the patients’clinicopathologic parameters and laboratory inspections,such as age, sex, histopathology, TNM stage, and blood cell count. Tumor stages were determined according to the 7thedition of the TNM classification17.

    F-NLR definition

    Hematological indexes, including lymphocyte count,neutrophil count, and fibrinogen concentration, were obtained from the routine blood test administered a week prior to the surgery. The neutrophil count divided by the lymphocyte count was defined as the NLR. Receiver operating characteristic (ROC) curve analysis was used to determine the cut-off values for the preoperative fibrinogen concentration and NLR. According to the ROC curve analysis, the most appropriate cut-off point for NLR was 2.30, with an area under the curve of 0.635. Therefore, we recommended 2.30 as the cut-off value for NLR. Similarly,the optimal point based on the ROC curve showed a cut-off value of 3.48 g/L for fibrinogen, with an area under the curve of 0.595. Consequently, we defined 3.48 g/L as the optimal cut-off value for fibrinogen.

    Based on these cut-off values, we calculated the F-NLR score. Patients with both a high NLR (≥ 2.30) and hyperfibrinogenemia (≥ 3.48 g/L) were given a score of 2.Patients with either high NLR (≥ 2.30) or hyperfibrinogenemia (≥ 3.48 g/L) were given a score of 1. Patients without either abnormality were scored 0.

    Statistical analysis

    Chi-square and Kruskal-Wallis tests were applied to evaluate the differences between the three F-NLR groups and the clinicopathologic characteristics or clinical laboratory variables. Continuous variables are presented as mean ± SD.We carried out the ROC curve analysis to select the appropriate cut-off values for NLR, fibrinogen, and the clinical laboratory variables. These clinical laboratory variables included fibrinogen, lactate dehydrogenase (LDH),D-dimer, neutrophil ratio, monocyte ratio, lymphocyte ratio,white blood cell (WBC) count, platelet count, hemoglobin(Hb), and alkaline phosphatase (ALP). The outcomes of this study were disease-free survival (DFS) and overall survival(OS). DFS was defined as the time in months from the date of surgery to the date of first progression or last follow-up.OS was defined as the time in months from the date of surgery to the date of death or last follow-up. Survival analysis was performed using the Kaplan-Meier survival curve. Univariate and multivariate analyses, which were carried out by Cox regression models, were used to determine the prognostic factors. SPSS version 18.0 (SPSS Inc., Chicago, IL) was utilized for statistical analyses. A P value of < 0.05 was considered statistically significant.

    Results

    Patient characteristics

    A total of 589 patients who were pathologically diagnosed with NSCLC were included in this study. All patients underwent surgery for early-stage NSCLC. Tables 1 and 2 illustrate the relationship of the clinicopathologic variables and clinical laboratory parameters with patients grouped by their F-NLR score. The present study included 390 (66.2%)men and 199 (33.8%) women, ranging 24–82 years (medianage: 60 years). The allocation of the F-NLR score was as follows: F-NLR = 0, 207 (35.1%) patients; F-NLR = 1, 154(26.2%) patients; and F-NLR = 2, 228 (38.7%) patients. A total of 278, 120, and 191 patients presented with pathological stages I, II, and IIIA, respectively. The median and mean follow-up periods were 44 and 44.3 months,respectively. The five-year OS rate in the entire study population was 50.3%.

    Table 1 Correlation between preoperative F-NLR and clinicopathologic characteristics of patients with NSCLC

    Table 2 Correlation between preoperative F-NLR and clinical laboratory characteristics of patients with NSCLC

    Correlation between the clinicopathologic variables or clinical laboratory parameters and F-NLR

    The association between the F-NLR and clinicopathologic indexes of patients with NSCLC is shown in Table 1. We found significant correlation of F-NLR with age (P = 0.005),gender (P = 0.006), smoking (P = 0.014), lesion (P < 0.001),resection type (P < 0.001), pathological stage (P < 0.001),histology (P < 0.001), lymph node metastasis (P = 0.028),and tumor size (P < 0.001).

    The clinical laboratory variable distribution in the three FNLR groups is presented in Table 2. Significant differences among these three groups were demonstrated in the following indexes: age (P = 0.001), maximum tumor diameter (P < 0.001), NLR (P < 0.001), fibrinogen (P <0.001), neutrophil ratio (P < 0.001), lymphocyte ratio (P <0.001), WBC count (P < 0.001), platelet count (P < 0.001),ALP (P < 0.001), and survival period (P < 0.001).

    Survival analysis of F-NLR

    We performed the Kaplan-Meier analysis and log-rank test to determine the survival differences among the three groups classified by F-NLR score. The five-year DFS rate and the median survival in patients with F-NLR = 2 were significantly lower than those in patients with F-NLR = 1 or F-NLR = 0[30.4% vs. 50.3% or 62.2% (22.5 vs. 36.0 or 42.0 months),P < 0.001; Figure 1A]. The five-year OS rates were 66.1%,53.5%, and 33.3%, and the median survival times were 51.0,46.0, and 33.0 months for F-NLR = 0, F-NLR = 1, and F-NLR= 2, respectively (P < 0.001, Figure 1B). When the pathological stages (I, II, and IIIA) were analyzed separately,the DFS and OS of patients with F-NLR = 0 were higher than those with F-NLR = 1 or F-NLR = 2 in stages I and IIIA(stage I: P < 0.001 for DFS, P < 0.001 for OS, Figures 2A and 2B; stage IIIA: P = 0.001 for DFS, P < 0.001 for OS, Figures 2E and 2F). However, no significant relationship was observed between F-NLR and prognosis in patients with stage II NSCLC (P = 0.149 for DFS and P = 0.139 for OS,Figures 2C and 2D). Further analyses were conducted in subgroups (adenocarcinoma and squamous carcinoma). We demonstrated that patients with F-NLR = 0 displayed a higher DFS and OS than those with F-NLR = 1 or F-NLR = 2 in the adenocarcinoma and squamous carcinoma subgroups(adenocarcinoma: P < 0.001 for DFS, P < 0.001 for OS,Figures 3A and 3B; squamous carcinoma: P < 0.001 for DFS,P < 0.001 for OS, Figures 3C and 3D).

    Figure 1 Survival curves of patients with non-small cell lung cancer (NSCLC) (stages I-IIIA) in the combination of fibrinogen and neutrophil-to-lymphocyte ratio (F-NLR). (A) Disease-free survival (DFS) curve of patients with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001). (B) Overall survival (OS) curve of patients with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test,P > 0.001).

    Univariate and multivariate analyses of variables are shown in Tables 3 and 4, respectively. Based on the cut-off values, we separated the patients into different groups.Univariate analysis demonstrated that lesion (P = 0.023 for DFS and P = 0.014 for OS), resection type (P = 0.041 for DFS and P = 0.038 for OS), pathological stage (P < 0.001 for DFS and P < 0.001 for OS), tumor size (P < 0.001 for DFS and P <0.001 for OS), adjuvant radiotherapy (P = 0.001 for DFS and P = 0.004 for OS), F-NLR score (P < 0.001 for DFS and P <0.001 for OS), NLR (P < 0.001 for DFS and P < 0.001 for OS), fibrinogen (P < 0.001 for DFS and P < 0.001 for OS),LDH (P = 0.003 for DFS and P = 0.005 for OS), D-dimer(P < 0.001 for DFS and P = 0.002 for OS), neutrophil ratio(P < 0.001 for DFS and P < 0.001 for OS), monocyte ratio(P = 0.008 for DFS and P = 0.006 for OS), lymphocyte ratio(P < 0.001 for DFS and P < 0.001 for OS), WBC count (P =0.007 for DFS and P = 0.008 for OS), ALP (P = 0.002 for DFS and P = 0.003 for OS), and Hb (P = 0.022 for DFS and P =0.040 for OS) were correlated with DFS and OS.

    Multivariate analysis of independent prognostic indicators

    Figure 2 Survival curves of patients with NSCLC (stage I-IIIA) in F-NLR. (A) DFS curve of patients with stage I NSCLC with F-NLR=0, FNLR=1, and F-NLR=2 (log-rank test, P > 0.001). (B) OS curve of patients with stage I NSCLC with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001). (C) DFS curve of patients with stage II NSCLC with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P = 0.149). (D) OS curve of patients with stage II NSCLC with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P = 0.139). (E) DFS curve of patients with stage IIIA NSCLC with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P = 0.001). (F) OS curve of patients with stage IIIA NSCLC with F-NLR=0, FNLR=1, and F-NLR=2 (log-rank test, P > 0.001).

    Figure 3 Survival curves of patients with adenocarcinoma or squamous carcinoma in F-NLR. (A) DFS curve of patients with adenocarcinoma with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001). (B) OS curve of patients with adenocarcinoma with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001).(C) DFS curve of patients with squamous carcinoma with F-NLR=0,F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001). (D) OS curve of patients with squamous carcinoma with F-NLR=0, F-NLR=1, and F-NLR=2 (log-rank test, P > 0.001).

    To determine the independent predictive indexes, further Cox multivariate analysis, which included the variables mentioned above, was performed. As shown in Table 4,multivariate analysis revealed that F-NLR was significantly related to DFS and OS [hazard ratio (HR), 1.466; 95%confidence interval (CI), 1.243–1.730; P < 0.001 for DFS and HR, 1.512; 95% CI, 1.283–1.783; P < 0.001 for OS,respectively] along with pathological stage and D-dimer.Therefore, multivariate analysis demonstrated that F-NLR was considered an independent prognostic indicator for DFS and OS.

    Discussion

    Although substantial developments have been made in the treatment and diagnosis of lung cancer, the median survival of NSCLC remains unsatisfactory. An appropriate prognostic factor may enable the suitable risk classification of patients with tumors and allow the assignment of appropriate prospective treatment. Cancer progression and survival are not determined solely by the tumor characteristics. Patientrelated factors also play a crucial role in survival. Based on the preoperative blood specimens collected from 589 patients, we investigated the prognostic significance of FNLR. We also analyzed the association between F-NLR and clinicopathologic or clinical laboratory characteristics.

    In the last few decades, inflammation has been increasingly accepted as a hallmark of cancer3. Inflammation can increase the risk of cancer by producing bioactive molecules from the cells infiltrating the tumor microenvironment. Inflammationrelated cells introduce crucial cytokines to the tumor microenvironment, thereby promoting the growth,angiogenesis, invasion, metastasis, and survival of cancer cells18-20. Increasing evidence has revealed that systemic inflammation responses are crucial prognostic indicators21.NLR is a systemic inflammation index, which is calculated by dividing the neutrophil count by the lymphocyte count.Lymphocytes, as key components of the host’s anticancer immunity, perform important functions in immunosurveillance and immunoediting and contribute to the inhibition of tumor cell proliferation and migration21. T lymphocytes exert a killing effect on target cells and help induce tumor cell apoptosis in cancer patients22. Increased amounts of circulating blood lymphocytes are an advantageous prognostic index in resected NSCLC23,24. Similar to lymphocytes, neutrophils are recognized as important components of tumor inflammation and immunology.Circulating neutrophils can produce a variety of cytokines,including tumor necrosis factor-α, vascular endothelial growth factor (VEGF), and interleukin, which can promote tumor progression25,26. Neutrophil extracellular traps, which are secreted by neutrophils, can contribute to tumor metastasis by sequestering the tumor cell27. Donskov28reported that increased neutrophil levels infiltrating the tumor tissue and circulating in the blood are insufficient prognostic indexes in several cancers, including colorectal cancer, lung cancer, and head and neck cancer. With the combination of neutrophil and lymphocyte counts, NLR can be used as a representative index to indicate a systemic inflammatory response in patients with various cancers6-8.

    Hyperfibrinogenemia is involved in tumor aggressiveness in various malignancies10-12. Although many studies have investigated the causes of hyperfibrinogenemia in malignant tumors, the underlying mechanism remains unclear. Liverproduced fibrinogen is a major acute-phase protein. When a malignant neoplasm or systemic inflammation is present, the fibrinogen level in the plasma is increased; this fibrinogen can be transformed into fibrin by activated thrombin. Yamaguchi et al.29indicated that cancer cells can produce interleukin-6,which accelerates the secretion of fibrinogen in patients with lung cancer. Similarly, Sahni et al.30found that tumor cellscan synthesize fibrinogen. Fibrinogen eventually stimulates tumor proliferation and angiogenesis by its interaction with VEGF and fibroblast growth factor-230,31. When fibrinogen is converted, fibrin is involved in metastasis and new vessel formation32,33. Palumbo et al.34demonstrated that the fibrin formed around circulating tumor cells can prevent natural killer cells from killing tumor cells.

    Table 3 Univariate analysis for DFS and OS

    Hence, F-NLR presents a good prognostic indicator for patients with cancer. Fibrinogen or NLR alone may exert a limited effect on tumor progression. F-NLR increases the unfavorable effect of fibrinogen and NLR, which eventually increases the predicted significance for patients with cancer.Recently, Wang et al.16reported that patients with a low FNLR score may exhibit a better prognosis than those with a high F-NLR score and that the preoperative F-NLR score can be considered a useful independent prognostic marker,consistent with the results of our study. In the present study,multivariate analysis using the characteristics selected in univariate analysis revealed that preoperative F-NLR was significantly correlated with DFS and OS, as well as pathological stage and D-dimer. According to the results of the Kaplan-Meier analysis and log-rank test, our study revealed that the preoperative F-NLR level can stratify the patients into different risk categories. Moreover, when the patients with different pathological stages were analyzed separately, the DFS and OS in the patients with F-NLR = 0 were higher than those with F-NLR = 1 or F-NLR = 2 in stage I and IIIA. However, in patients with stage II NSCLC, thecorrelation between F-NLR and prognosis was insignificant,which indicates that F-NLR may be more predictive in stage I or IIIA cancers than in stage II. Our study also found that the preoperative F-NLR level was significantly correlated with both DFS and OS in patients with adenocarcinoma or squamous carcinoma. Furthermore, a close relationship was observed between F-NLR and pathological stage, lesion,lymph node metastasis, and tumor size. To reveal the pathological status of tumor progression, preoperative FNLR levels calculated from blood specimens should be evaluated. The advantage of the F-NLR score was based on the fibrinogen concentration and NLR, which were obtained from the routine blood sample analysis. Therefore, F-NLR may serve as a more inexpensive and widespread hematologic marker than other tumor markers.

    Table 4 Multivariate analysis for DFS and OS

    This study had some limitations. First, this study was a retrospective analysis and all data were obtained from a single institute. Second, although we restricted the influence of other factors, blood cell counts can be influenced by a variety of factors.

    Conclusions

    The preoperative F-NLR score can be considered a valuable prognostic indicator in patients with NSCLC after surgery. A close relationship between F-NLR and cancer progression was also observed in patients with NSCLC who underwent surgery. Thus, F-NLR may be considered for routine clinical use as a reliable and low-cost biomarker.

    This work was supported by grants from National Key R&D Program of China (Grant No. 2016YFC0905501) and the Tianjin Science and Technology Major Project, China (Grant No. 12ZCDZSY15400).

    Conflict of interest statement

    No potential conflicts of interest are disclosed.

    1.Siegel R, Ma JM, Zou ZH, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29.

    2.Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-74.

    3.Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancerrelated inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009; 30: 1073-81.

    4.Scott HR, McMillan DC, Forrest LM, Brown DJF, McArdle CS,Milroy R. The systemic inflammatory response, weight loss,performance status and survival in patients with inoperable nonsmall cell lung cancer. Br J Cancer. 2002; 87: 264-7.

    5.Guthrie GJK, Charles KA, Roxburgh CSD, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophillymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol. 2013; 88: 218-30.

    6.Takahashi Y, Horio H, Hato T, Harada M, Matsutani N, Morita S,et al. Prognostic significance of preoperative neutrophil-lymphocyte ratios in patients with stage I non-small cell lung cancer after complete resection. Ann Surg Oncol. 2015; 22:1324-31.

    7.Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI,et al. Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.Ann Surg Oncol. 2011; 18: 3362-9.

    8.Cho IR, Park JC, Park CH, Jo JH, Lee HJ, Kim S, et al. Pretreatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. 2014; 17:703-10.

    9.Zacharski LR, Meehan KR, Algarra SM, Calvo FA. Clinical trials with anticoagulant and antiplatelet therapies. Cancer Metastasis Rev. 1992; 11: 421-31.

    10.Son HJ, Park JW, Chang HJ, Kim DY, Kim BC, Kim SY, et al.Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol. 2013; 20: 2908-13.

    11.Lu K, Zhu Y, Sheng LM, Liu LY, Shen L, Wei QC. Serum fibrinogen level predicts the therapeutic response and prognosis in patients with locally advanced rectal cancer. Hepatogastroenterology. 2011;58: 1507-10.

    12.Sheng LM, Luo M, Sun XJ, Lin NM, Mao WM, Su D. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. Int J Cancer. 2013; 133: 2720-5.

    13.Arigami T, Uenosono Y, Matsushita D, Yanagita S, Uchikado Y,Kita Y, et al. Combined fibrinogen concentration and neutrophillymphocyte ratio as a prognostic marker of gastric cancer. Oncol Lett. 2016; 11: 1537-44.

    14.Arigami T, Uenosono Y, Ishigami S, Okubo K, Kijima T, Yanagita S, et al. A novel scoring system based on fibrinogen and the neutrophil-lymphocyte ratio as a predictor of chemotherapy response and prognosis in patients with advanced gastric cancer.Oncology. 2016; 90: 186-92.

    15.Arigami T, Okumura H, Matsumoto M, Uchikado Y, Uenosono Y,Kita Y, et al. Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosis. Medicine (Baltimore).2015; 94: e1702

    16.Wang HY, Zhao J, Zhang MY, Han LJ, Wang M, Li XD. The combination of plasma fibrinogen and neutrophil lymphocyte ratio(F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. J Cell Physiol. 2017; doi: 10.1002/jcp.26239. (in Press)

    17.Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming(seventh) edition of the TNM Classification of malignant tumours.J Thorac Oncol. 2007; 2: 706-14.

    18.DeNardo DG, Andreu P, Coussens LM. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 2010; 29: 309-16.

    19.Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140: 883-99.

    20.Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010; 141: 39-51.

    21.Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454: 436-44.

    22.Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W,Lotze M, et al. Decreased ζ chain expression and apoptosis in CD3+peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res. 2001; 7: 947S-57S.

    23.Zhang J, Huang SH, Li H, Li Y, Chen XL, Zhang WQ, et al.Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol.2013; 30: 352

    24.Kobayashi N, Usui S, Kikuchi S, Goto Y, Sakai M, Onizuka M, et al.Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer. 2012;75: 223-7.

    25.Ulich TR, del Castillo J, Keys M, Granger GA, Ni RX. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-α-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol. 1987; 139: 3406-15.

    26.Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH.Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003; 6: 283-7.

    27.Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S,Giannias B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest. 2013;123: 3446-58.

    28.Donskov F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013; 23: 200-7.

    29.Yamaguchi T, Yamamoto Y, Yokota S, Nakagawa M, Ito M, Ogura T. Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients. Jpn J Clin Oncol. 1998; 28:740-4.

    30.Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW.Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost.2008; 6: 176-83.

    31.Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.Blood. 2000; 96: 3772-8.

    32.Wojtukiewicz MZ, Sierko E, Klemont P, Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia. 2001; 3: 371-84.

    33.Chiarug V, Ruggiero M, Magnelli L. Angiogenesis and the unique nature of tumor matrix. Mol Biothechnol. 2002; 21: 85-90.

    34.Palumbo JS, Talmage KE, Massari JV, La jeunesse CM, Flick MJ,Kombrinck KW, et al. Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood. 2005; 105: 178-85.

    又爽又黄a免费视频| av卡一久久| 小说图片视频综合网站| 国产在线男女| 午夜精品一区二区三区免费看| 国产91av在线免费观看| 国产真实乱freesex| 69av精品久久久久久| 国产男人的电影天堂91| 久久久成人免费电影| 又粗又爽又猛毛片免费看| 搞女人的毛片| 亚洲av中文字字幕乱码综合| videos熟女内射| 热99re8久久精品国产| 成人无遮挡网站| 午夜福利在线观看吧| 卡戴珊不雅视频在线播放| 最近中文字幕高清免费大全6| 久久久久久久久久黄片| 亚洲伊人久久精品综合 | 亚洲成人中文字幕在线播放| 亚洲成人精品中文字幕电影| 久久欧美精品欧美久久欧美| 欧美人与善性xxx| 日韩成人伦理影院| 18+在线观看网站| 精品久久久久久久久久久久久| 麻豆乱淫一区二区| 国产亚洲精品久久久com| 18禁裸乳无遮挡免费网站照片| 卡戴珊不雅视频在线播放| 在线观看美女被高潮喷水网站| 久久精品综合一区二区三区| 国内揄拍国产精品人妻在线| 黄片无遮挡物在线观看| 中文天堂在线官网| 国产av码专区亚洲av| 少妇高潮的动态图| 午夜免费男女啪啪视频观看| 国产 一区 欧美 日韩| 99视频精品全部免费 在线| 少妇的逼水好多| 国产精品野战在线观看| 亚洲在线自拍视频| 99久久成人亚洲精品观看| 欧美高清性xxxxhd video| 老司机福利观看| 国产v大片淫在线免费观看| 久99久视频精品免费| 少妇人妻精品综合一区二区| 久99久视频精品免费| 午夜爱爱视频在线播放| 最近手机中文字幕大全| 99久久无色码亚洲精品果冻| 日韩亚洲欧美综合| 狠狠狠狠99中文字幕| 精品久久国产蜜桃| 99热网站在线观看| 亚洲国产欧洲综合997久久,| 久久久久久伊人网av| 日本wwww免费看| 亚洲av中文av极速乱| 国产精品一区二区性色av| 成人亚洲欧美一区二区av| 欧美日本视频| 欧美高清成人免费视频www| av专区在线播放| 国产又色又爽无遮挡免| 尤物成人国产欧美一区二区三区| 在线播放国产精品三级| 亚洲内射少妇av| 亚州av有码| 亚洲av一区综合| 亚洲人与动物交配视频| 亚洲图色成人| 国产大屁股一区二区在线视频| 欧美3d第一页| 国产综合懂色| 国产乱人偷精品视频| 午夜精品一区二区三区免费看| 亚洲国产精品国产精品| 国产精品永久免费网站| 国产v大片淫在线免费观看| 日本黄色片子视频| 美女高潮的动态| 天堂影院成人在线观看| 看片在线看免费视频| 看十八女毛片水多多多| 国产精品一区二区三区四区免费观看| 一个人看的www免费观看视频| 大话2 男鬼变身卡| 欧美日韩精品成人综合77777| 五月玫瑰六月丁香| 色吧在线观看| 九九久久精品国产亚洲av麻豆| 亚洲欧美成人综合另类久久久 | 99九九线精品视频在线观看视频| av视频在线观看入口| 男女视频在线观看网站免费| 亚洲五月天丁香| 国模一区二区三区四区视频| 亚洲欧美日韩高清专用| 一级黄片播放器| 久热久热在线精品观看| 日韩一区二区视频免费看| 内射极品少妇av片p| 国产黄片美女视频| 精品少妇黑人巨大在线播放 | 男女国产视频网站| 欧美性猛交黑人性爽| 嫩草影院新地址| 美女xxoo啪啪120秒动态图| 乱人视频在线观看| 免费看美女性在线毛片视频| 免费大片18禁| 日本免费a在线| 国产成人a∨麻豆精品| 国产成人aa在线观看| 男人狂女人下面高潮的视频| 久久久久久久国产电影| 亚洲久久久久久中文字幕| 精品人妻一区二区三区麻豆| 亚洲av成人精品一区久久| 国产毛片a区久久久久| h日本视频在线播放| 精品国产一区二区三区久久久樱花 | 欧美激情久久久久久爽电影| av在线亚洲专区| 日日摸夜夜添夜夜添av毛片| 欧美变态另类bdsm刘玥| 免费av观看视频| 国产日韩欧美在线精品| 午夜免费男女啪啪视频观看| 国内精品一区二区在线观看| 小蜜桃在线观看免费完整版高清| 中文资源天堂在线| 日韩,欧美,国产一区二区三区 | 淫秽高清视频在线观看| 一区二区三区四区激情视频| 日韩av在线大香蕉| 久久韩国三级中文字幕| 免费黄色在线免费观看| 亚洲人成网站在线播| 高清在线视频一区二区三区 | 日本黄色视频三级网站网址| 男的添女的下面高潮视频| 亚洲真实伦在线观看| 亚洲成人精品中文字幕电影| 国产精品一及| 日本猛色少妇xxxxx猛交久久| 免费搜索国产男女视频| 久久人人爽人人片av| 国产成人精品一,二区| 国产精品人妻久久久久久| 国产黄片美女视频| 亚洲精品亚洲一区二区| 亚洲怡红院男人天堂| 99九九线精品视频在线观看视频| 91在线精品国自产拍蜜月| 天天躁日日操中文字幕| 毛片女人毛片| 三级毛片av免费| 成人二区视频| 午夜久久久久精精品| 青春草视频在线免费观看| 赤兔流量卡办理| 日韩,欧美,国产一区二区三区 | 综合色av麻豆| 成年av动漫网址| 中文字幕人妻熟人妻熟丝袜美| 91狼人影院| 欧美最新免费一区二区三区| 精品一区二区三区人妻视频| 国产一区二区在线观看日韩| 免费不卡的大黄色大毛片视频在线观看 | 色综合色国产| 天堂中文最新版在线下载 | 国产黄a三级三级三级人| av国产久精品久网站免费入址| 国产真实乱freesex| 人妻系列 视频| 国产精品电影一区二区三区| 高清视频免费观看一区二区 | 尾随美女入室| 夫妻性生交免费视频一级片| 22中文网久久字幕| 免费电影在线观看免费观看| 亚洲精品国产成人久久av| 六月丁香七月| 麻豆精品久久久久久蜜桃| 国产91av在线免费观看| 小蜜桃在线观看免费完整版高清| 九草在线视频观看| 日本黄大片高清| 丰满人妻一区二区三区视频av| 国产亚洲午夜精品一区二区久久 | 亚洲人成网站在线观看播放| 看免费成人av毛片| 久久精品国产鲁丝片午夜精品| 精品久久久噜噜| 99热这里只有精品一区| 免费人成在线观看视频色| 国产探花极品一区二区| 一级黄色大片毛片| 村上凉子中文字幕在线| 伦理电影大哥的女人| 国产精品乱码一区二三区的特点| 在线天堂最新版资源| 亚洲精品乱久久久久久| 一区二区三区四区激情视频| 国产91av在线免费观看| 国产精品1区2区在线观看.| 亚洲欧美精品自产自拍| 看非洲黑人一级黄片| 久久精品影院6| 天天躁日日操中文字幕| 久久久国产成人精品二区| 午夜免费男女啪啪视频观看| 亚洲中文字幕一区二区三区有码在线看| 国产精品福利在线免费观看| 亚洲av福利一区| 99久久无色码亚洲精品果冻| 国产在视频线精品| 嘟嘟电影网在线观看| 久久亚洲国产成人精品v| 日本wwww免费看| 亚洲一区高清亚洲精品| 亚洲av二区三区四区| 简卡轻食公司| 亚洲精品456在线播放app| 99久久成人亚洲精品观看| 中国美白少妇内射xxxbb| 国产探花极品一区二区| 亚洲中文字幕日韩| 91aial.com中文字幕在线观看| 亚洲国产精品sss在线观看| 看非洲黑人一级黄片| 国产成人免费观看mmmm| 国产精品国产三级专区第一集| 国产一区二区三区av在线| 菩萨蛮人人尽说江南好唐韦庄 | 国产亚洲最大av| 少妇高潮的动态图| 亚洲av福利一区| 久久久久网色| 一级黄色大片毛片| 久久久久久伊人网av| 91久久精品国产一区二区成人| av播播在线观看一区| 亚洲欧美日韩无卡精品| 最近最新中文字幕免费大全7| 嫩草影院精品99| 国产精品久久久久久av不卡| 国产淫片久久久久久久久| 一卡2卡三卡四卡精品乱码亚洲| 夜夜爽夜夜爽视频| 黄色一级大片看看| 99视频精品全部免费 在线| 国产精品无大码| 国产av不卡久久| 国产精品久久久久久av不卡| 国产精品一二三区在线看| a级一级毛片免费在线观看| 欧美区成人在线视频| 精品久久久久久久久亚洲| 中国国产av一级| av女优亚洲男人天堂| 1024手机看黄色片| 又爽又黄无遮挡网站| 女的被弄到高潮叫床怎么办| 国产大屁股一区二区在线视频| 内射极品少妇av片p| 日韩一本色道免费dvd| 高清av免费在线| 亚洲欧美日韩高清专用| 亚洲图色成人| 特级一级黄色大片| 中文字幕av成人在线电影| 天堂√8在线中文| 亚洲四区av| 国产 一区 欧美 日韩| 99久久九九国产精品国产免费| 亚洲成人中文字幕在线播放| 九九热线精品视视频播放| 久久久色成人| 国产91av在线免费观看| 欧美+日韩+精品| 欧美日韩在线观看h| 少妇裸体淫交视频免费看高清| 久久精品国产亚洲网站| 精品国内亚洲2022精品成人| 大香蕉久久网| 精华霜和精华液先用哪个| 午夜亚洲福利在线播放| 亚洲成人久久爱视频| 国产免费又黄又爽又色| 国产精品久久久久久久电影| 亚洲国产精品专区欧美| 男女视频在线观看网站免费| 欧美成人精品欧美一级黄| 国产伦一二天堂av在线观看| 国产极品天堂在线| a级毛片免费高清观看在线播放| 在线免费十八禁| a级一级毛片免费在线观看| 日韩av在线免费看完整版不卡| 国产一区二区在线av高清观看| 99在线视频只有这里精品首页| 亚洲在线自拍视频| av.在线天堂| 国产私拍福利视频在线观看| videossex国产| 老女人水多毛片| 九九在线视频观看精品| 亚洲综合色惰| av视频在线观看入口| 晚上一个人看的免费电影| 三级经典国产精品| 少妇被粗大猛烈的视频| 校园人妻丝袜中文字幕| 亚洲国产成人一精品久久久| 少妇高潮的动态图| 日日撸夜夜添| 国产精品嫩草影院av在线观看| 直男gayav资源| h日本视频在线播放| 亚洲怡红院男人天堂| av视频在线观看入口| 国产精品久久电影中文字幕| 色网站视频免费| 村上凉子中文字幕在线| 男女国产视频网站| 美女高潮的动态| 亚洲无线观看免费| 久久欧美精品欧美久久欧美| 九色成人免费人妻av| 大香蕉97超碰在线| 一级爰片在线观看| 一区二区三区高清视频在线| 少妇被粗大猛烈的视频| av国产久精品久网站免费入址| 亚洲在线自拍视频| 国内少妇人妻偷人精品xxx网站| 男女边吃奶边做爰视频| 精品一区二区三区视频在线| 久久这里有精品视频免费| 欧美日本亚洲视频在线播放| 嫩草影院新地址| 特大巨黑吊av在线直播| 高清午夜精品一区二区三区| 国产男人的电影天堂91| 国产成人aa在线观看| 日日摸夜夜添夜夜添av毛片| 日韩欧美精品v在线| 色综合色国产| 婷婷色综合大香蕉| 午夜福利在线观看吧| 夜夜爽夜夜爽视频| 又粗又爽又猛毛片免费看| av在线天堂中文字幕| 国产视频内射| 免费av观看视频| 亚洲精品日韩av片在线观看| 国产免费视频播放在线视频 | 99国产精品一区二区蜜桃av| 女的被弄到高潮叫床怎么办| 精品国产一区二区三区久久久樱花 | 中国国产av一级| 成人亚洲精品av一区二区| 插逼视频在线观看| 爱豆传媒免费全集在线观看| 国产片特级美女逼逼视频| 亚洲无线观看免费| 久久精品久久久久久噜噜老黄 | 不卡视频在线观看欧美| 热99在线观看视频| 一区二区三区免费毛片| 日韩视频在线欧美| 汤姆久久久久久久影院中文字幕 | 婷婷色综合大香蕉| 一本一本综合久久| 日韩在线高清观看一区二区三区| 精品久久久久久久久亚洲| 国产免费视频播放在线视频 | 久久人妻av系列| 22中文网久久字幕| 超碰av人人做人人爽久久| 内地一区二区视频在线| 亚洲av日韩在线播放| 国产一区二区在线av高清观看| 久久久久性生活片| 特级一级黄色大片| 亚洲一级一片aⅴ在线观看| 成人av在线播放网站| 亚洲无线观看免费| 国产不卡一卡二| 一区二区三区乱码不卡18| 国产午夜精品一二区理论片| 亚洲精品久久久久久婷婷小说 | 日本黄色片子视频| 免费av不卡在线播放| 最近最新中文字幕免费大全7| 国产黄色视频一区二区在线观看 | 亚洲欧洲日产国产| 日本黄色片子视频| 国产熟女欧美一区二区| 国产亚洲最大av| av黄色大香蕉| 亚洲精品久久久久久婷婷小说 | 蜜桃久久精品国产亚洲av| 男的添女的下面高潮视频| av视频在线观看入口| 国产精品电影一区二区三区| 精品国产三级普通话版| 精品久久久久久久末码| 国产激情偷乱视频一区二区| 亚洲乱码一区二区免费版| 国产片特级美女逼逼视频| 九草在线视频观看| 免费不卡的大黄色大毛片视频在线观看 | 在线免费观看的www视频| 久久久久性生活片| 九九在线视频观看精品| 中文字幕熟女人妻在线| 国产大屁股一区二区在线视频| 2021天堂中文幕一二区在线观| 插阴视频在线观看视频| 亚洲性久久影院| 精品一区二区免费观看| 免费看日本二区| 日本免费一区二区三区高清不卡| 亚洲欧美日韩卡通动漫| 啦啦啦观看免费观看视频高清| 哪个播放器可以免费观看大片| 在线免费十八禁| 一个人看的www免费观看视频| 嫩草影院精品99| 直男gayav资源| 自拍偷自拍亚洲精品老妇| 天天躁日日操中文字幕| 看黄色毛片网站| 久久久久久久久久黄片| 亚洲国产高清在线一区二区三| 男人狂女人下面高潮的视频| 国产免费一级a男人的天堂| 六月丁香七月| 99热精品在线国产| 亚洲国产精品专区欧美| 女人被狂操c到高潮| 亚洲国产高清在线一区二区三| 一二三四中文在线观看免费高清| 欧美潮喷喷水| 国产成人91sexporn| a级毛色黄片| 欧美日韩综合久久久久久| 久久精品综合一区二区三区| 亚洲人与动物交配视频| 亚洲色图av天堂| 欧美一区二区国产精品久久精品| 丝袜喷水一区| 免费看a级黄色片| 国产人妻一区二区三区在| 国产精品国产高清国产av| 久久久久久久午夜电影| 国产在视频线在精品| 哪个播放器可以免费观看大片| 国产麻豆成人av免费视频| 日本黄色视频三级网站网址| 国产免费视频播放在线视频 | 在线免费十八禁| av天堂中文字幕网| 91久久精品国产一区二区三区| 精品99又大又爽又粗少妇毛片| 国产三级在线视频| 亚洲国产色片| 亚洲经典国产精华液单| 久久久久久久久久黄片| 高清毛片免费看| 哪个播放器可以免费观看大片| 午夜激情欧美在线| 国产高潮美女av| 在线免费十八禁| 身体一侧抽搐| 亚洲最大成人手机在线| 黄色日韩在线| 一夜夜www| 小蜜桃在线观看免费完整版高清| 日韩三级伦理在线观看| 国产精品蜜桃在线观看| 蜜臀久久99精品久久宅男| 午夜爱爱视频在线播放| 国产极品精品免费视频能看的| 日日摸夜夜添夜夜爱| 伦精品一区二区三区| 亚洲精品色激情综合| 老司机福利观看| 国产一区二区三区av在线| 少妇人妻精品综合一区二区| 日本免费在线观看一区| 久久午夜福利片| 免费av观看视频| 九色成人免费人妻av| 久久久久久久久久久丰满| 精华霜和精华液先用哪个| 国产单亲对白刺激| 熟女电影av网| 男女视频在线观看网站免费| 国产亚洲精品av在线| 国产亚洲91精品色在线| 中文字幕人妻熟人妻熟丝袜美| 少妇丰满av| 如何舔出高潮| 欧美日本亚洲视频在线播放| 一级黄片播放器| 午夜福利网站1000一区二区三区| 大香蕉97超碰在线| 欧美区成人在线视频| 午夜福利在线观看吧| 国产白丝娇喘喷水9色精品| 午夜亚洲福利在线播放| 久久精品国产亚洲av涩爱| 男女下面进入的视频免费午夜| 嘟嘟电影网在线观看| 日韩一本色道免费dvd| 熟女人妻精品中文字幕| 我的老师免费观看完整版| 性色avwww在线观看| 日本免费在线观看一区| 最后的刺客免费高清国语| 亚洲经典国产精华液单| 男女视频在线观看网站免费| 欧美不卡视频在线免费观看| 精品免费久久久久久久清纯| 欧美激情国产日韩精品一区| 在线观看美女被高潮喷水网站| 国产成人一区二区在线| 变态另类丝袜制服| 亚洲国产成人一精品久久久| 哪个播放器可以免费观看大片| 91精品国产九色| 五月伊人婷婷丁香| 一卡2卡三卡四卡精品乱码亚洲| 黄片wwwwww| 熟女人妻精品中文字幕| 欧美又色又爽又黄视频| 久久99热6这里只有精品| 黄片无遮挡物在线观看| 最近2019中文字幕mv第一页| 亚洲av日韩在线播放| 久久久国产成人免费| 国产高潮美女av| 熟女人妻精品中文字幕| 国产乱人视频| 51国产日韩欧美| 国产熟女欧美一区二区| 春色校园在线视频观看| 天天一区二区日本电影三级| 日韩成人av中文字幕在线观看| 日韩国内少妇激情av| 狠狠狠狠99中文字幕| 国产精品不卡视频一区二区| 国产精品女同一区二区软件| 在线播放无遮挡| 男女国产视频网站| 国产精品不卡视频一区二区| 免费大片18禁| 国产精品一区二区三区四区免费观看| 久久6这里有精品| 两性午夜刺激爽爽歪歪视频在线观看| 岛国在线免费视频观看| 国产毛片a区久久久久| 亚洲aⅴ乱码一区二区在线播放| 欧美不卡视频在线免费观看| 日日干狠狠操夜夜爽| 精品酒店卫生间| 久久午夜福利片| 亚洲欧美精品自产自拍| 美女cb高潮喷水在线观看| 午夜福利网站1000一区二区三区| a级毛色黄片| 国产 一区精品| 免费黄网站久久成人精品| 草草在线视频免费看| 中文在线观看免费www的网站| 国产私拍福利视频在线观看| 又爽又黄a免费视频| 免费不卡的大黄色大毛片视频在线观看 | av国产免费在线观看| 成年av动漫网址| 国产精品一及| 亚洲人成网站高清观看| 国产av不卡久久| 在线播放无遮挡| 两个人视频免费观看高清| 女人久久www免费人成看片 | 岛国毛片在线播放| 六月丁香七月| 国内精品美女久久久久久| 亚洲欧美中文字幕日韩二区| 国产精品国产三级专区第一集| 亚洲国产成人一精品久久久| 久久99热这里只有精品18| 精品久久久久久久久久久久久| 日日撸夜夜添| 大又大粗又爽又黄少妇毛片口| 我要看日韩黄色一级片| www.av在线官网国产| videossex国产| 国产高潮美女av| 欧美3d第一页| 亚洲欧洲国产日韩| 亚洲天堂国产精品一区在线| 一边亲一边摸免费视频| 日日摸夜夜添夜夜添av毛片|